Correlation Between GlaxoSmithKline PLC and US Treasury

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and US Treasury at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and US Treasury into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and US Treasury 7, you can compare the effects of market volatilities on GlaxoSmithKline PLC and US Treasury and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of US Treasury. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and US Treasury.

Diversification Opportunities for GlaxoSmithKline PLC and US Treasury

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GlaxoSmithKline and USVN is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and US Treasury 7 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Treasury 7 and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with US Treasury. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Treasury 7 has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and US Treasury go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and US Treasury

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the US Treasury. In addition to that, GlaxoSmithKline PLC is 3.6 times more volatile than US Treasury 7. It trades about -0.3 of its total potential returns per unit of risk. US Treasury 7 is currently generating about 0.02 per unit of volatility. If you would invest  4,775  in US Treasury 7 on August 28, 2024 and sell it today you would earn a total of  6.00  from holding US Treasury 7 or generate 0.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  US Treasury 7

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
US Treasury 7 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US Treasury 7 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, US Treasury is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and US Treasury Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and US Treasury

The main advantage of trading using opposite GlaxoSmithKline PLC and US Treasury positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, US Treasury can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Treasury will offset losses from the drop in US Treasury's long position.
The idea behind GlaxoSmithKline PLC ADR and US Treasury 7 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios